Zeta Farmaceutici Group

What Zeta Farmaceutici Group does

Zeta Farmaceutici Group is a privately held Italian pharmaceutical manufacturer founded in 1947 and headquartered in Vicenza, with integrated operations spanning R&D, manufacturing, and distribution across two production sites in Sandrigo (Vicenza) and Mozzate (Como). The group employs approximately 410 collaborators plus a dedicated sales force of 110, and produces more than 50 million pieces per year across multiple dosage forms including liquids, semi-solids, powders, probiotics, and medical devices.

The company operates a multi-brand portfolio of six consumer brands distributed primarily through Italian pharmacies and parapharmacies: Euphidra (dermocosmetics and make-up), AmidoMio (rice starch-based sensitive skin care), Prolife (probiotics with CSQA-certified vitality-until-expiry), Massigen (vitamin and mineral supplements), Marco Viti (acquired 2001; medicines, medical devices, biocides), and the house Zeta Farmaceutici brand. Proprietary technology includes the DryFill production process maintaining water activity below 0.1 for probiotic stability, exclusive ActivRec single-dose PET vials with reservoir caps, and plastic-free Alu-Alu blister packaging. The group holds AIFA pharmaceutical authorization, cGMP certification, and a broad ISO stack (9001, 13485, 22716, 22000, 45001, 14001).

Zeta generates revenue through three streams: (1) own-brand distribution to over 10,000 Italian pharmacy and parapharmacy points of sale generating 62,000+ shipments annually, (2) CMO Pharma contract manufacturing services for large pharmaceutical companies including development, production, analytical/regulatory support, technology transfer, and clinical trial sampling, and (3) international licensing of brands and formulations across 30+ countries. Reported revenue reached approximately €143 million in 2023 and ~€140 million in 2024, reflecting maturity in its domestic pharmacy channel with ongoing international and CMO diversification.

Name

Zeta Farmaceutici Group

Legal name

ZETA FARMACEUTICI S.p.A.

Website

https://zetafarm.it

Company type

Private

Founded year

1947

Operating status

Operating

Short description

Zeta Farmaceutici Group is a privately held Italian pharmaceutical manufacturer (founded 1947) producing and distributing a portfolio of six consumer health brands — including Euphidra, Prolife, Massigen, and Marco Viti — through 10,000+ Italian pharmacies, with additional CMO contract manufacturing and international licensing across 30+ countries.

Ownership category

akta.pro rank

Product category

Pharmaceutical Manufacturing and Consumer Health Products

NAICS

Pharmaceutical Preparation Manufacturing (325412)

SIC

Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Generic Finished Dosage Form (FDF) Manufacturing (HLAIABAH)

akta.pro secondary industry

Vitamins & Minerals (Single Nutrients) (CRADAGAB)

Keywords

• Pharmaceutical manufacturing
• Contract manufacturing pharma
• Probiotic supplements
• Dermocosmetics products
• Medical devices production

Headquarters

HQ city

Sandrigo

HQ country

Italy

HQ region

Europe

Offices3 records

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Own Brand Products: Development, production and distribution of proprietary brands including Euphidra (cosmetics, makeup), AmidoMio (rice starch-based products for sensitive skin), Prolife (probiotics), Massigen (dietary supplements), Marco Viti (pharmaceuticals, medical devices, biocides). Products sold through pharmacies and parapharmacies across Italy and international markets.
2. Contract Manufacturing (CMO Pharma): Pharmaceutical contract manufacturing services for large pharma companies including development and production, analytical and regulatory support, technology transfer, and clinical trial sampling. Specializes in liquid forms (nasal drops/sprays, stickpacks, single-dose vials), probiotics, and specialized products including corticosteroids with AIFA authorization.
3. Licensing: Licensing of brands and products for international distribution in wellness, supplements, and cosmetics markets. Offers complete product range with pharmaceutical quality formulations for flexible market-specific needs.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels3 records

Core offering

Zeta Farmaceutici Group develops, manufactures, and distributes pharmaceuticals, medical devices, cosmetics, dietary supplements, probiotics, and biocides through its own consumer brands (Euphidra, AmidoMio, Prolife, Massigen, Marco Viti, Zeta Farmaceutici). The group operates two certified manufacturing sites in Italy producing 50+ million pieces annually, distributing to over 10,000 Italian pharmacies and parapharmacies and 30+ countries internationally. It also offers B2B contract manufacturing (CMO Pharma) services and licensing of its brands to international distributors.

Product overview

Zeta Farmaceutici Group is an Italian pharmaceutical and cosmetics company offering a portfolio of consumer health brands and B2B contract manufacturing services. The product portfolio consists of six main consumer brands: Euphidra (dermocosmetics and make-up), AmidoMio (rice starch-based sensitive skin care), Prolife (probiotics), Massigen (dietary supplements), Marco Viti (pharmaceuticals and medical devices), and the house Zeta Farmaceutici brand. Product categories span medicines (farmaci), medical devices (dispositivi medici), cosmetics (cosmetici), dietary supplements (integratori alimentari), and biocides. The group also operates B2B services including CMO Pharma (contract manufacturing) and Licensing for third-party commercialization of its brands and formulations.

Differentiator

Problem solved

Functional benefit

Brands

• Euphidra: Make-up, skin care, hair colour, personal hygiene, fragrance ranges. Dermocosmetics brand sold in pharmacy and parapharmacy.
• AmidoMio
• Prolife
• Massigen
• Marco Viti
• Zeta Farmaceutici

Products and services

• Euphidra Dermocosmetics brand offering make-up, skin care, hair colour, personal hygiene, and fragrance ranges with dermatologically tested Italian-produced formulas for pharmacy and parapharmacy retail.
• AmidoMio Rice starch-based dermocosmetics line for cleansing and protecting sensitive and delicate skin, suitable from birth; sold in pharmacies and parapharmacies.
• Prolife High-concentration live lactic acid bacteria probiotic supplements with CSQA-certified probiotic vitality until expiry date; the only probiotics in Europe with this certification.
• Massigen Brand of vitamin and mineral dietary supplements and tonics (magnesium, potassium, multivitamin formulations) designed for daily energy and wellbeing support.
• Marco Viti Pharmaceutical brand offering medicines, medical devices, biocides, dietary supplements, and cosmetics distributed via the Mozzate (CO) production site.
• Zeta Farmaceutici (House Brand) Main group brand covering medicines, medical devices, dietary supplements, and cosmetics distributed through Italian pharmacies and parapharmacies.
• VITILAX Microclismi DM Medical device in micro-enema form for treating constipation and associated disorders, with adult and children formulations.
• Artrogen Product line for joint and muscle pain relief including Artrogen Articolazioni, Artrogen Articolazioni Advance, and Artrogen DM variants.
• ColoProXD Permanent hair colouring product with hyaluronic acid, free from ammonia, resorcinol, and parabens, sold in pharmacies.
• CMO Pharma Contract Manufacturing Services B2B contract manufacturing for large pharmaceutical companies including development and production, analytical and regulatory support, technology transfer, and clinical trial sampling. Specializes in liquid forms, probiotics, and corticosteroids with AIFA authorization.
• International Brand Licensing Licensing of Zeta Farmaceutici brands and products for commercialization in international wellness, supplements, and cosmetics markets, with flexible formulations for market-specific needs.

Quantifiable outcome

• Probiotic vitality certified until product expiry by CSQA (only in Europe)
• +4 more outcomes

Named customers1 record

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Scale indicators14 records

Recent moves10 records

Expansion highlights5 records

Direct peers

• Fine Foods & Pharmaceuticals N.T.M. Fine Foods is an Italian CDMO producing pharmaceuticals, nutraceuticals and cosmetics for third parties. It is highly comparable to Zeta’s CMO Pharma activities and overlapping supplement/cosmetic manufacturing capabilities.
• Doppel Farmaceutici: Doppel Farmaceutici is an Italian pharmaceutical and nutraceutical contract development and manufacturing company. It competes most directly with Zeta on B2B pharma manufacturing, formulation and regulated production services.
• Unifarco: Unifarco develops and manufactures pharmacy-channel cosmetics, supplements and health products. It is comparable to Zeta’s Euphidra, AmidoMio and Massigen lines because both serve pharmacies with branded consumer-health portfolios.
• Montefarmaco OTC: Montefarmaco OTC markets self-medication products, supplements, medical devices and personal-care products through pharmacies. It is comparable to Zeta’s own-brand OTC and pharmacy distribution model in Italy.
• PharmaNutra: PharmaNutra develops nutritional supplements and medical devices sold largely through pharmacy and healthcare channels. It overlaps with Zeta’s Massigen, Prolife and medical-device positioning, though it is less exposed to contract manufacturing.
• Sofar: Sofar is an Italian pharmaceutical company with gastrointestinal, probiotic, medical-device and supplement products. It is comparable to Zeta’s Prolife and Marco Viti portfolios in the Italian pharmacy channel.
• Named Group: Named Group is an Italian consumer-health company focused on supplements, natural health and pharmacy-channel products. It is comparable to Zeta’s Massigen and Prolife brands and its emphasis on nutraceuticals sold through healthcare retail.
• Aboca: Aboca develops and manufactures natural therapeutic products, medical devices and supplements sold through pharmacies and international channels. It is comparable as an Italian consumer-health manufacturer with strong pharmacy-channel distribution, though with a more botanical/natural-health focus.

Broad incumbents

• Alfasigma: Alfasigma is a larger Italian pharmaceutical group active in prescription medicines, OTC products and consumer health. It is a broad incumbent relative to Zeta, with overlapping pharmacy and healthcare product exposure but a wider global pharma portfolio.
• Angelini Pharma: Angelini Pharma is an established European pharmaceutical company with prescription and consumer-health products. It is comparable as a larger incumbent selling healthcare products through pharmacy channels, although its scope is broader than Zeta’s mid-market branded and CMO mix.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/ZetaFarmaceutici
• LinkedInlinkedin.com/company/zeta-farmaceutici-spa

Compliance8 records

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Zeta Farmaceutici Group